| Company Name [asc] | Country |
|---|---|
| Solisa Consult GmbH | Germany |
| Solstice Pharmaceuticals B.V. | Netherlands |
| SOM Innovation Biotech S.A. | Spain |
| Somerville Development Partners BV | Netherlands |
| Spago Nanomedical AB | Sweden |
| SparingVision SAS | France |
| Specialty Therapeutics PC | Greece |
| SpectraCure AB | Sweden |
| SpectrumX Pharmaceuticals Limited | Ireland |
| Spedding Research Solutions SAS | France |
| Spinal Cord Technologies S.L. | Spain |
| Splicebio, SL | Spain |
| SQ Innovation BV | Netherlands |
| SQY Therapeutics | France |
| St. Louis Group EU B.V. | Netherlands |
| Stablepharma Spain S.L. | Spain |
| STALICLA R&D S.L. | Spain |
| Starodub B.V. | Netherlands |
| Stayble Therapeutics AB | Sweden |
| Steba Biotech SA | Luxembourg |
| Steden Pharma BV | Netherlands |
| Steierl-Pharma GmbH | Germany |
| Stem4Cells PSA | Poland |
| StemInov SAS | France |
| StemSight Oy | Finland |
| STEP PHARMA SAS | France |
| Stewart Italia S.r.l. | Italy |
| Stichting Lygature | Netherlands |
| Stilvi Pharmaceuticals S.A. | Greece |
| Stirolbiofarm Baltikum SIA | Latvia |
| Strallhofer Pharma GmbH | Austria |
| Strike Pharma AB | Sweden |
| StromaCare | France |
| Sublin BV | Netherlands |
| Sudahim EOOD | Bulgaria |
| Südmedica GmbH | Germany |
| Supremex Kft. | Hungary |
| SurgiMab SAS | France |
| Sveikuva UAB | Lithuania |
| Swan Pond Investments Ltd | Ireland |
|
|
|